Matched Unrelated Allogeneic Stem Cell Transplantation
Showing 1 - 25 of >10,000
Multiple Myeloma Trial in Hamburg (allogeneic HSCT)
Completed
- Multiple Myeloma
- allogeneic HSCT
-
Hamburg, GermanyUniversity Medical Center Hamburg-Eppendorf
Sep 1, 2022
Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)
Recruiting
- Myeloid Malignancies
- +3 more
- Cyclophosphamide
- +7 more
-
Houston, TexasM D Anderson Caner Center
Nov 17, 2022
Hematological Malignancies Trial in Philadelphia (radiation, drug, genetic)
Recruiting
- Hematological Malignancies
- Total Body Irradiation
- +6 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 4, 2022
Hematologic Diseases Trial in Palo Alto (Allogeneic Stem Cell Transplant, CliniMACS TCR a/ß Reagent Kit and CliniMACS CD19)
Recruiting
- Hematologic Diseases
- Allogeneic Stem Cell Transplant
- CliniMACS TCR α/β Reagent Kit and CliniMACS CD19
-
Palo Alto, CaliforniaLucile Packard Children's Hospital
Feb 2, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic
Recruiting
- Acute Lymphoblastic Leukemia
- +16 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 1, 2022
Leukemia, Lymphoma, Myelodysplasia Trial in Philadelphia (Alpha Beta T cell depletion)
Recruiting
- Leukemia
- +2 more
- Alpha Beta T cell depletion
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Oct 27, 2021
SIOD With CKD Stage 3 Through 5, Cystinosis With CKD Stage 3 Through 5, FSGS With CKD Stage 3 Through 5 Trial in Palo Alto
Not yet recruiting
- SIOD With CKD Stage 3 Through 5
- +3 more
- Cyclophosphamide 1200 mg/Kg
- +8 more
-
Palo Alto, CaliforniaLucile Packard Children's Hospital
Aug 17, 2022
Hematologic Diseases Trial in Palo Alto (biological, device, drug)
Recruiting
- Hematologic Diseases
- Allogeneic Stem Cell Transplant
- +2 more
-
Palo Alto, CaliforniaLucile Packard Children's Hospital
Mar 25, 2022
Acute Myeloid Leukemia in Remission, Acute Lymphoblastic Leukemia in Remission, MDS Trial in Worldwide (Allogeneic Stem Cell
Recruiting
- Acute Myeloid Leukemia in Remission
- +2 more
- Allogeneic Stem Cell Transplantation
-
Graz, Austria
- +23 more
Oct 3, 2021
Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Maywood (Atorvastatin, Methotrexate,
Withdrawn
- Acute Myeloid Leukemia
- +2 more
- Atorvastatin
- +2 more
-
Maywood, IllinoisLoyola University Medical Center
Apr 23, 2021
Severe Combined Immune Deficiency (SCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)
Enrolling by invitation
- Severe Combined Immune Deficiency (SCID)
- Sirolimus
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Bethesda, Minneapolis (biological, drug,
Recruiting
- Myelodysplastic Syndrome
- +4 more
- Rituximab
- +6 more
-
Bethesda, Maryland
- +1 more
Aug 20, 2022
Inherited Immune Deficiencies Trial run by the NIAID (Campath 1H, Busulfan, Horse Anti-human Thymocyte Globulin (h-ATG))
Completed
- Inherited Immune Deficiencies
- Campath 1H
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 20, 2021
Leukemia, Myeloid, Acute Trial in Germany (Human Stem Cell Transplantation, Consolidation chemo, i.e. High-dose Cytarabine
Terminated
- Leukemia, Myeloid, Acute
- Human Stem Cell Transplantation
- Consolidation chemotherapy, i.e. High-dose Cytarabine (HiDAC)
-
Aachen, Germany
- +18 more
Oct 28, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, California
- +1 more
Sep 22, 2023
Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)
Not yet recruiting
- Hematopoietic Stem Cell Transplantation
- Hematologic Malignancy
- CliniMACS®
- (no location specified)
Oct 17, 2023
Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))
Not yet recruiting
- Leukemia
- +12 more
- Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
- (no location specified)
Mar 20, 2023
GATA2, Immunodeficiency Trial run by the National Cancer Institute (NCI) (drug, radiation, procedure)
Not yet recruiting
- GATA2
- Immunodeficiency
- Mycophenolate Mofetil
- +7 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 23, 2023
Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in
Not yet recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
- Fludarabine
- +2 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Aug 31, 2023
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New Hyde Park (radiation, drug,
Completed
- Acute Lymphoblastic Leukemia
- +5 more
- Radiation
- +3 more
-
New Hyde Park, New YorkCohen Children's Medical Center
Apr 6, 2022
Blood Disease Trial (TCRaß+/CD19+ depleted Hematopoietic stem cell (HSC) graft, CliniMACS® System)
Not yet recruiting
- Blood Disease
- TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
- CliniMACS® System
- (no location specified)
Jan 30, 2023
AML/MDS Trial in Copenhagen (iDLI)
Recruiting
- AML/MDS
- iDLI
-
Copenhagen, DenmarkCopenhagen University Hospital, Rigshospitalet
Jan 13, 2023
Hodgkin Lymphoma Trial in Valhalla (Brentuximab Vedotin, Allogeneic Stem Cell Transplantation, Reduced Intensity Conditioning)
Active, not recruiting
- Hodgkin Lymphoma
- Brentuximab Vedotin
- +2 more
-
Valhalla, New YorkNew York Medical College
Oct 24, 2022
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Minneapolis (drug, biological, radiation)
Completed
- Leukemia
- +2 more
- busulfan
- +3 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Nov 12, 2020